State of Wyoming’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-325
Closed -$26.7K 1710
2024
Q2
$26.7K Buy
+325
New +$35.1K ﹤0.01% 1526
2024
Q1
Sell
-2,227
Closed -$205K 1639
2023
Q4
$205K Buy
2,227
+1,690
+315% +$172K 0.04% 531
2023
Q3
$88.6K Buy
+537
New +$69.8K 0.02% 937
2023
Q2
Sell
-561
Closed -$19.1K 1580
2023
Q1
$19.1K Buy
+561
New +$29.3K 0.01% 1428
2022
Q2
Sell
-116
Closed -$64K 1903
2022
Q1
$64K Buy
116
+39
+51% +$23.6K 0.03% 904
2021
Q4
$51K Sell
77
-3
-4% -$2.29K 0.02% 1082
2021
Q3
$67K Buy
+80
New +$81.2K 0.04% 639

Other funds holding CDLX

State of Wyoming's CDLX Position: Q3 2024 in Review

State of Wyoming sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 325 shares — an estimated $26.7K sold.

State of Wyoming first reported a position in CDLX in Q3 2021 and held it in 7 quarters. The position peaked at $205K in Q4 2023. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • State of Wyoming reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • State of Wyoming sold 325 Cardlytics shares in Q3 2024, an estimated $26.7K.
  • State of Wyoming first reported a position in Cardlytics in Q3 2021 and held it in 7 quarters.
  • State of Wyoming's Cardlytics position peaked at $205K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on State of Wyoming's 13F filing for Q3 2024, filed 14 Nov 2024.